- Report
- January 2026
- 200 Pages
Global
From €4706EUR$4,995USD£3,918GBP
- Report
- January 2026
- 200 Pages
Global
From €4706EUR$4,995USD£3,918GBP
- Report
- January 2026
- 200 Pages
Global
From €4706EUR$4,995USD£3,918GBP
- Report
- January 2026
- 180 Pages
Global
From €4240EUR$4,500USD£3,530GBP
- Clinical Trials
- April 2026
- 1883 Pages
Global
From €3250EUR$3,450USD£2,706GBP
- Report
- October 2026
- 22 Pages
Global
From €16954EUR$17,995USD£14,116GBP
- Report
- October 2026
- 218 Pages
Global
From €16954EUR$17,995USD£14,116GBP
- Report
- October 2026
- 219 Pages
Global
From €16954EUR$17,995USD£14,116GBP
- Clinical Trials
- September 2026
- 755 Pages
Global
From €3250EUR$3,450USD£2,706GBP
- Report
- September 2026
- 93 Pages
Global
From €9417EUR$9,995USD£7,840GBP
- Clinical Trials
- April 2026
- 152 Pages
Global
From €3250EUR$3,450USD£2,706GBP
- Report
- April 2026
- 158 Pages
Global
From €16954EUR$17,995USD£14,116GBP
- Report
- March 2026
- 177 Pages
Global
From €16954EUR$17,995USD£14,116GBP
- Clinical Trials
- February 2026
- 361 Pages
Global
From €3250EUR$3,450USD£2,706GBP
- Clinical Trials
- February 2026
- 4673 Pages
Global
From €3250EUR$3,450USD£2,706GBP
- Report
- February 2026
- 86 Pages
Global
From €9417EUR$9,995USD£7,840GBP
- Report
- February 2026
- 134 Pages
Global
From €16954EUR$17,995USD£14,116GBP
- Report
- February 2026
- 83 Pages
Global
From €3293EUR$3,495USD£2,742GBP
- Clinical Trials
- December 2025
- 219 Pages
Global
From €3250EUR$3,450USD£2,706GBP
- Report
- December 2025
- 72 Pages
Global
From €16954EUR$17,995USD£14,116GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more